UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

Journal of clinical oncology, 1995-11, Vol.13 (11), p.2737-2744

1995

Volltextzugriff (PDF)

I-V characteristics of single and clustered ligand stabilized cobalt nanoparticles on highly oriented pyrolytic graphite obtained with conducting atomic force microscopy under ambient conditions

Journal of applied physics, 2012-11, Vol.112 (10)

2012

Volltextzugriff (PDF)

A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer

Cancer investigation, 2000, Vol.18 (6), p.521-529

2000

Volltextzugriff (PDF)

Inclusion of patients and advocates as authors in medical publications: progress over the past decade

Sleep medicine, 2024-02, Vol.115, p.254-254

2024

Volltextzugriff (PDF)

767 poster PARTIAL BREAST IRRADIATION WITH CONCURRENT DOSE DENSE DOXORUBICIN & CYCLOPHOSPHAMIDE: LATE TOXICITY & RECURRENCE

Radiotherapy and oncology, 2011, Vol.99, p.S302-S303

2011

Volltextzugriff (PDF)

750 poster COSMETIC OUTCOME AFTER PARTIAL BREAST IRRADIATION WITH CONCURRENT CHEMOTHERAPY IN EARLY-STAGE BREAST CANCER

Radiotherapy and oncology, 2011, Vol.99, p.S297-S297

2011

Volltextzugriff (PDF)

Factors affecting treatment decisions for a life-threatening illness: The case of medical treatment of breast cancer

Social science & medicine (1982), 1991, Vol.32 (7), p.813-818

1991

Volltextzugriff (PDF)

Doctor-patient communication about breast cancer adjuvant therapy

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1192-1200

1989

Volltextzugriff (PDF)

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study

Journal of clinical oncology, 1998-07, Vol.16 (7), p.2382-2391

1998

Volltextzugriff (PDF)

Use of hematopoietic colony-stimulating factors : The American society of clinical oncology survey

Journal of clinical oncology, 1996-09, Vol.14 (9), p.2511-2520

1996

Volltextzugriff (PDF)

Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer

The New England journal of medicine, 2003-07, Vol.349 (1), p.17-26

2003

Volltextzugriff (PDF)

Abstract P3-12-02: Predictors of adherence to adjuvant endocrine therapy (ET) for early breast cancer (BC) in a prospective clinic-based cohort

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-12-02

2018

Volltextzugriff (PDF)

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Breast cancer research and treatment, 2018-08, Vol.171 (1), p.121-129

2018

Volltextzugriff (PDF)

The prevalence of psychiatric disorders among cancer patients

JAMA : the journal of the American Medical Association, 1983-02, Vol.249 (6), p.751

1983

Volltextzugriff (PDF)

Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions

Medical decision making, 1989-10, Vol.9 (4), p.262-271

1989

Volltextzugriff (PDF)

Quality-of-Life Assessment in Cancer Clinical Trials: A Status Report

JNCI : Journal of the National Cancer Institute, 1992-07, Vol.84 (13), p.994-995

1992

Volltextzugriff (PDF)

Long term follow‐up of women treated with 16‐week, dose‐intensive adjuvant chemotherapy for high risk breast carcinoma

Cancer, 1999-02, Vol.85 (4), p.899-904

1999

Volltextzugriff (PDF)

Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells

British Journal of Cancer, 2000-12, Vol.83 (11), p.1405-1411

2000

Volltextzugriff (PDF)

Evaluating quality and quantity of life in breast cancer adjuvant trials

Journal of clinical oncology, 1988-12, Vol.6 (12), p.1795-1797

Fetting, J H

1988

Volltextzugriff (PDF)

A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer

Cancer chemotherapy and pharmacology, 1999, Vol.43 (6), p.497-502

1999

Volltextzugriff (PDF)

Triple-negative breast cancer (TNBC) outcomes with partial breast irradiation and concurrent chemotherapy (PBI-CC) compared with whole breast irradiation and sequential chemotherapy (WBI-SC)

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.115-115

2011

Volltextzugriff (PDF)

Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study

Journal of clinical oncology, 1990-09, Vol.8 (9), p.1476-1482

1990

Volltextzugriff (PDF)

A multi-institutional double-blind phase II study evaluating response and surrogate biomarkers to carboplatin and nab-paclitaxel (CP) with or without vorinostat as preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer (TBCRC008)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS111-TPS111

2010

Volltextzugriff (PDF)

A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1067-1067

2011

Volltextzugriff (PDF)

Abstract S2-1: Obesity at Diagnosis Is Associated with Inferior Outcomes in Hormone Receptor Positive Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.S2-S2-1

2010

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(103)
Deutsch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Humans
(58)
Life Sciences & Biomedicine
(55)
Female
(45)
Oncology
(42)
Middle Aged
(35)
Adult
(32)
Biological And Medical Sciences
(32)
Medical Sciences
(29)
Breast Neoplasms - Drug Therapy
(27)
Aged
(22)
Pharmacology. Drug Treatments
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Breast Cancer
(14)
Antineoplastic Agents
(13)
Cyclophosphamide - Administration & Dosage
(13)
Chemotherapy
(12)
Quality Of Life
(12)
Breast Neoplasms - Therapy
(11)
Doxorubicin - Administration & Dosage
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy

I-V characteristics of single and clustered ligand stabilized cobalt nanoparticles on highly oriented pyrolytic graphite obtained with conducting atomic force microscopy under ambient conditions

A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer

Inclusion of patients and advocates as authors in medical publications: progress over the past decade

767 poster PARTIAL BREAST IRRADIATION WITH CONCURRENT DOSE DENSE DOXORUBICIN & CYCLOPHOSPHAMIDE: LATE TOXICITY & RECURRENCE

750 poster COSMETIC OUTCOME AFTER PARTIAL BREAST IRRADIATION WITH CONCURRENT CHEMOTHERAPY IN EARLY-STAGE BREAST CANCER

Factors affecting treatment decisions for a life-threatening illness: The case of medical treatment of breast cancer

Doctor-patient communication about breast cancer adjuvant therapy

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study

Use of hematopoietic colony-stimulating factors : The American society of clinical oncology survey

Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer

Abstract P3-12-02: Predictors of adherence to adjuvant endocrine therapy (ET) for early breast cancer (BC) in a prospective clinic-based cohort

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

The prevalence of psychiatric disorders among cancer patients

Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions

Quality-of-Life Assessment in Cancer Clinical Trials: A Status Report

Long term follow‐up of women treated with 16‐week, dose‐intensive adjuvant chemotherapy for high risk breast carcinoma

Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells

Evaluating quality and quantity of life in breast cancer adjuvant trials

A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer

Triple-negative breast cancer (TNBC) outcomes with partial breast irradiation and concurrent chemotherapy (PBI-CC) compared with whole breast irradiation and sequential chemotherapy (WBI-SC)

Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study

A multi-institutional double-blind phase II study evaluating response and surrogate biomarkers to carboplatin and nab-paclitaxel (CP) with or without vorinostat as preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer (TBCRC008)

A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC)

Abstract S2-1: Obesity at Diagnosis Is Associated with Inferior Outcomes in Hormone Receptor Positive Breast Cancer

Suchergebnisse filtern